United States: FDA Allows Pharmacists To Prescribe The COVID-19 Antiviral Paxlovid - Foley & Lardner

On July 6, the FDA revised its emergency use authorization (EUA) for the COVID-19 antiviral treatment PaxlovidTM (nirmatrelvir and ritonavir) to allow prescribing by pharmacists for quicker and easier access for patients.